95 related articles for article (PubMed ID: 11303512)
1. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.
Kytölä S; Villablanca A; Ebeling T; Nord B; Larsson C; Höög A; Wong FK; Välimäki M; Vierimaa O; Teh BT; Salmela PI; Leisti J
J Med Genet; 2001 Mar; 38(3):185-9. PubMed ID: 11303512
[No Abstract] [Full Text] [Related]
2. Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients.
Cebrián A; Ruiz-Llorente S; Cascón A; Pollán M; Díez JJ; Picó A; Tellería D; Benítez J; Robledo M
J Med Genet; 2003 May; 40(5):e72. PubMed ID: 12746426
[No Abstract] [Full Text] [Related]
3. Identification of three novel menin mutations (c.741delGTCA, c.1348T>C, c.1785delA) in unrelated Italian families affected with multiple endocrine neoplasia type 1: Additional information for mutational screening.
Asteria C; Faglia G; Roncoroni R; Borretta G; Ribotto P; Beck-Peccoz P
Hum Mutat; 2001 Mar; 17(3):237. PubMed ID: 11241849
[No Abstract] [Full Text] [Related]
4. The European Consortium on MEN1. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1).
Hum Genet; 1997 Oct; 100(5-6):657-65. PubMed ID: 9341888
[No Abstract] [Full Text] [Related]
5. 11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes.
Emmert-Buck MR; Debelenko LV; Agarwal S; Kester MB; Manickam P; Zhuang Z; Guru SC; Olufemi SE; Burns AL; Chandrasekharappa SC; Lubensky IA; Liotta LA; Skarulis MC; Spiegel AM; Marx SJ; Collins FS
Mol Genet Metab; 1998 Feb; 63(2):151-5. PubMed ID: 9562970
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
7. A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene.
Kopp P
Eur J Endocrinol; 1997 Sep; 137(3):222-3. PubMed ID: 9330583
[No Abstract] [Full Text] [Related]
8. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
Agarwal SK; Debelenko LV; Kester MB; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Heppner C; Crabtree JS; Lubensky IA; Zhuang Z; Kim YS; Chandrasekharappa SC; Collins FS; Liotta LA; Spiegel AM; Burns AL; Emmert-Buck MR; Marx SJ
Hum Mutat; 1998; 12(2):75-82. PubMed ID: 9671267
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system.
Toliat MR; Berger W; Ropers HH; Neuhaus P; Wiedenmann B
Lancet; 1997 Oct; 350(9086):1223. PubMed ID: 9652567
[No Abstract] [Full Text] [Related]
10. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
[TBL] [Abstract][Full Text] [Related]
11. [Identification of the gene associated with type 1 multiple endocrine neoplasia (NEM 1) susceptibility: a new pathway in the pathogenesis of neuro-endocrine tumors].
Calender A
Bull Cancer; 1997 Oct; 84(10):993-5. PubMed ID: 9435804
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases.
Poncin J; Abs R; Velkeniers B; Bonduelle M; Abramowicz M; Legros JJ; Verloes A; Meurisse M; Van Gaal L; Verellen C; Koulischer L; Beckers A
Hum Mutat; 1999; 13(1):54-60. PubMed ID: 9888389
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
Lourenço DM; Toledo RA; Mackowiak II; Coutinho FL; Cavalcanti MG; Correia-Deur JE; Montenegro F; Siqueira SA; Margarido LC; Machado MC; Toledo SP
Eur J Endocrinol; 2008 Sep; 159(3):259-74. PubMed ID: 18524795
[TBL] [Abstract][Full Text] [Related]
14. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
15. Menin mutations in MEN1 patients.
Mayr B; Brabant G; von zur Mühlen A
J Clin Endocrinol Metab; 1998 Aug; 83(8):3004-5. PubMed ID: 9709985
[No Abstract] [Full Text] [Related]
16. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
Gadelha MR; Prezant TR; Une KN; Glick RP; Moskal SF; Vaisman M; Melmed S; Kineman RD; Frohman LA
J Clin Endocrinol Metab; 1999 Jan; 84(1):249-56. PubMed ID: 9920092
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
[TBL] [Abstract][Full Text] [Related]
18. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.
Olufemi SE; Green JS; Manickam P; Guru SC; Agarwal SK; Kester MB; Dong Q; Burns AL; Spiegel AM; Marx SJ; Collins FS; Chandrasekharappa SC
Hum Mutat; 1998; 11(4):264-9. PubMed ID: 9554741
[TBL] [Abstract][Full Text] [Related]
19. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefèvre syndrome patients.
Zhang Y; Lundgren T; Renvert S; Tatakis DN; Firatli E; Uygur C; Hart PS; Gorry MC; Marks JJ; Hart TC
J Med Genet; 2001 Feb; 38(2):96-101. PubMed ID: 11158173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
